Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Mayo Clinic, Wyeth-Ayerst plan fen/phen study

Aug. 29, 1997

Review of fenfluramines points to neurotoxicity

Aug. 29, 1997

FDA wants stronger warning labels for fen/phen

Aug. 29, 1997

First regulatory submission filed for Macritonin

Aug. 28, 1997

CURVES study results point in favor of atorvastatin

Aug. 28, 1997

FDA approves nonsurgical treatment for BPH

Aug. 28, 1997

Roche withdraws NDA for orlistat

Aug. 28, 1997

Ergo Science submits NDA for Ergoset

Aug. 27, 1997

Biologics license issued for Carticel

Aug. 27, 1997

Bone-targeted carbonic anhydrase inhibitors from RCT

Aug. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...